T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Emergent Biosolutions
EBS
$230M
| $51.1M | 0.01% |
883,570
-5,769
| -0.6% | -$332K |
|
|
CERN
777
DELISTED
Cerner Corp
CERN
| $51.1M | 0.01% |
810,796
+61,555
| +8% | +$4.38M |
|
|
TVRD
778
Tvardi Therapeutics
TVRD
$22.1M
| $51.1M | 0.01% |
107,372
-22,090
| -17% | -$12M |
|
|
FBMS
779
DELISTED
The First Bancshares, Inc.
FBMS
| $50.7M | 0.01% |
2,660,742
+497,590
| +23% | +$14.9M |
|
|
PRA
780
DELISTED
ProAssurance
PRA
| $50.5M | 0.01% |
2,018,453
+62,441
| +3% | +$1.88M |
|
781
Cirrus Logic
CRUS
$6.08B
| $50.4M | 0.01% |
768,657
+50,576
| +7% | +$3.74M |
|
782
Semtech
SMTC
$12.4B
| $50.4M | 0.01% |
1,343,775
+392,519
| +41% | +$17.8M |
|
783
Copart
CPRT
$27.2B
| $50M | 0.01% |
2,919,388
+139,620
| +5% | +$3.11M |
|
784
Qualys
QLYS
$6.78B
| $50M | 0.01% |
574,210
-322
| -0.1% | -$27K |
|
785
Ormat Technologies
ORA
$6.98B
| $49.9M | 0.01% |
737,855
+10,399
| +1% | +$784K |
|
786
Dime Commercial Bancshares
DCOM
$1.82B
| $49.9M | 0.01% |
2,355,931
-92,406
| -4% | -$2.61M |
|
|
ENV
787
DELISTED
ENVESTNET, INC.
ENV
| $49.7M | 0.01% |
923,339
+30,667
| +3% | +$2.2M |
|
|
PGRE
788
DELISTED
Paramount Group
PGRE
| $49.5M | 0.01% |
5,627,159
-494,819
| -8% | -$6.13M |
|
789
Kearny Financial
KRNY
$604M
| $49.4M | 0.01% |
5,754,643
+469,698
| +9% | +$5.41M |
|
790
Choice Hotels
CHH
$4.71B
| $49.2M | 0.01% |
802,494
+83,019
| +12% | +$7.54M |
|
791
Mesa Laboratories
MLAB
$633M
| $48.8M | 0.01% |
216,028
-21,790
| -9% | -$5.37M |
|
792
Planet Fitness
PLNT
$3.71B
| $48.6M | 0.01% |
998,851
+975,394
| +4,158% | +$68M |
|
|
SGI
793
Somnigroup International
SGI
$14B
| $48.6M | 0.01% |
4,450,868
-863,428
| -16% | -$16.4M |
|
|
AMRN
794
Amarin Corp
AMRN
$299M
| $48.5M | 0.01% |
606,763
+245,110
| +68% | +$81.4M |
|
795
IQVIA
IQV
$39.8B
| $48.5M | 0.01% |
449,308
+30,303
| +7% | +$4.33M |
|
796
HEICO Corp Class A
HEI.A
$38.1B
| $48.4M | 0.01% |
757,648
-3,909
| -0.5% | -$349K |
|
|
TGI
797
DELISTED
Triumph Group
TGI
| $48.4M | 0.01% |
7,157,239
+601,398
| +9% | +$11M |
|
798
Synchrony
SYF
$26.1B
| $48.4M | 0.01% |
3,005,185
-365,217
| -11% | -$10.6M |
|
|
DRNA
799
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $48.3M | 0.01% |
2,627,226
-653,798
| -20% | -$12.7M |
|
800
Dropbox
DBX
$7.81B
| $47.8M | 0.01% |
2,639,904
+246,581
| +10% | +$4.48M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.